SEARCH

Current Edition

Volume 5 Issue 2

Gerresheimer – Innovating for a Better Life

Gerresheimer is a leading global partner in the pharma and healthcare industry. With speciality products made of glass and plastic, the company contributes to health …

Continue Reading →
Volume 5 Issue 2

What is a Blockchain? Why it’s Perfect for Healthcare Applications?

Blockchain is a much talked about technology and is now relatively well established in the financial sector as a secure form of payment transfer – …

Continue Reading →
Volume 5 Issue 2

Adapting to an Everchanging Regulatory Landscape

Compliance in regulated laboratories isn’t static; the rules and guidance are constantly evolving to improve standards and the quality of drug products. However, the areas …

Continue Reading →
Volume 5 Issue 2

Understanding and Overcoming the Challenges of Flow Cytometry

Flow cytometry is a powerful analytical tool that is widely used throughout drug development in various capacities. With an understanding of the range of applications …

Continue Reading →
Volume 5 Issue 2

How to Hire a Translation Agency

8 Steps Every Clinical Team Should Take to Find the Right Translation Partner Choosing the right medical translation provider can help in-house regulatory and clinical …

Continue Reading →
Volume 5 Issue 2

Accessing Greater Dimensions of Biological Understanding Through LC-MS Proteomics

Proteomics has the potential to answer vital biological questions, optimise drug development and improve clinical care. Seeing these benefits, more researchers are embracing proteomic profiling, …

Continue Reading →
Volume 5 Issue 2

Working in Tandem: Formulation Science and Drug Delivery Device Design

The need to continue to innovate with drug delivery devices has been a focus for medical device companies over the past couple of decades. With …

Continue Reading →
Volume 5 Issue 2

Developing Stable Lentiviral Cell Lines

Lentiviral vectors (LVV) are commonly used as gene delivery tools for cell and gene therapies, notably chimeric antigen receptor (CAR) T cell therapies. Like other …

Continue Reading →
Volume 5 Issue 2

Manufacturing of Biological Tissues: Standardisation and Automation

The manufacturing of biological tissues responds to major societal challenges, but it also faces major issues, especially those related to the standardisation of manufacturing processes …

Continue Reading →
Volume 5 Issue 2

Advancing Cardiac Drug Discovery with Human Induced Pluripotent Stem Cell Technology

Despite having available treatments for most cardiac diseases there is an increasing need for more specific and effective therapies. To help drug developers advance smoothly …

Continue Reading →
Volume 5 Issue 2

How Scalable Manufacture will Enable Progress for Lentiviral Therapies

In the twenty years since the creation of the first effective CAR-T cells, lentiviral vectors have become valuable tools for the development of ex vivo …

Continue Reading →
Volume 5 Issue 2

Live Cell Transport – The New Way of Transportation

A new generation of active temperature-controlled and CO2-conditioned transport devices are challenging the existing cell shipment methods. In routine cell culture transport protocols, it is …

Continue Reading →
Volume 5 Issue 2

Preparing Biopharmaceutical Downstream Processing Supply Chains for Resiliency Post-Pandemic

From monoclonal antibodies (mAbs) that treat ailments such as cancer and arthritis to messenger RNA (mRNA) vaccines to fight a pandemic, biopharma’s place in global …

Continue Reading →